NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant
The USPTO issued a patent to NAPIGEN for the use of CRISPR technologies to edit organellar genomes. Separately, USDA awarded NAPIGEN an SBIR phase 1...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Ganesh Kishore. Real-time updates on events, politics, business and more.